Associations of metacognition with symptoms, insight, and neurocognition in clinically stable outpatients with schizophrenia
- PMID: 22759945
- DOI: 10.1097/NMD.0b013e31825bfb10
Associations of metacognition with symptoms, insight, and neurocognition in clinically stable outpatients with schizophrenia
Abstract
Research indicates that many with schizophrenia experience deficits in metacognitive capacity or the ability to form complex representations of themselves and others. Previous work has found that metacognitive capacity in schizophrenia is correlated with symptoms, insight, and neurocognitive deficits. We sought to replicate these results in a sample of Italian participants treated in a community setting. Metacognition was assessed with the abbreviated Metacognition Assessment Scale and correlated with concurrent assessment of symptoms, insight, and neurocognitive abilities, including verbal and visual memory, premorbid intelligence, processing speed, and executive function. Correlations revealed that, consistent with previous work, lesser capacity for self-reflectivity was related to greater levels of negative symptoms, poorer insight, neurocognitive impairment (particularly impairments in verbal and visual memory) premorbid intelligence, and processing speed. Other metacognitive domains were also linked to poorer neurocognition. Results support contentions that deficits in metacognition are linked with negative symptoms, insight, and neurocognitive deficits.
Similar articles
-
Metacognition within narratives of schizophrenia: associations with multiple domains of neurocognition.Schizophr Res. 2007 Jul;93(1-3):278-87. doi: 10.1016/j.schres.2007.02.016. Epub 2007 Apr 3. Schizophr Res. 2007. PMID: 17407806
-
Metacognition in schizophrenia: associations with multiple assessments of executive function.J Nerv Ment Dis. 2008 May;196(5):384-9. doi: 10.1097/NMD.0b013e3181710916. J Nerv Ment Dis. 2008. PMID: 18477880
-
Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life.Acta Psychiatr Scand. 2005 Jul;112(1):64-71. doi: 10.1111/j.1600-0447.2005.00514.x. Acta Psychiatr Scand. 2005. PMID: 15952947
-
Neurocognition in first-episode schizophrenia: a meta-analytic review.Neuropsychology. 2009 May;23(3):315-36. doi: 10.1037/a0014708. Neuropsychology. 2009. PMID: 19413446 Review.
-
[Characteristics and impact of metacognitive deficits in schizophrenia].Encephale. 2013 Apr;39(2):123-9. doi: 10.1016/j.encep.2012.01.009. Epub 2012 Dec 6. Encephale. 2013. PMID: 23219408 Review. French.
Cited by
-
A manual-based individual therapy to improve metacognition in schizophrenia: protocol of a multi-center RCT.BMC Psychiatry. 2014 Feb 3;14:27. doi: 10.1186/1471-244X-14-27. BMC Psychiatry. 2014. PMID: 24490942 Free PMC article. Clinical Trial.
-
A cognitive model of diminished expression in schizophrenia: The interface of metacognition, cognitive symptoms and language disturbances.J Psychiatr Res. 2020 Dec;131:169-176. doi: 10.1016/j.jpsychires.2020.09.008. Epub 2020 Sep 14. J Psychiatr Res. 2020. PMID: 32979692 Free PMC article.
-
Metacognition in Schizophrenia Spectrum Disorders-Current Methods and Approaches.Brain Sci. 2023 Jun 28;13(7):1004. doi: 10.3390/brainsci13071004. Brain Sci. 2023. PMID: 37508936 Free PMC article. Review.
-
Metacognition in schizophrenia: A practical overview of psychometric metacognition assessment tools for researchers and clinicians.Front Psychiatry. 2023 Apr 13;14:1155321. doi: 10.3389/fpsyt.2023.1155321. eCollection 2023. Front Psychiatry. 2023. PMID: 37124248 Free PMC article. Review.
-
Psychometric properties and validation of the metacognitive self-assessment scale (MSAS) in a Turkish sample.Front Psychol. 2024 Dec 12;15:1411733. doi: 10.3389/fpsyg.2024.1411733. eCollection 2024. Front Psychol. 2024. PMID: 39726613 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical